Cathepsin-regulated apoptosis

Apoptosis

Volumn 11, Issue 2, 2006, Pages 143-149

  Chwieralski, C E ^a   Welte, T ^b   Buhling F ^a,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CARL THIEM KLINIKUM   (Germany)

Author keywords

Apoptosis; Cathepsins; Lysosome; Protease

Indexed keywords

BLEOMYCIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; ENZYME INHIBITOR; LYSOSOME ENZYME;

APOPTOSIS; B LYMPHOCYTE; CANCER CELL; CD8+ T LYMPHOCYTE; CELL MUTANT; CONCENTRATION PROCESS; ENZYME INHIBITION; HELA CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKEMIA; LIVER CELL; LIVER INJURY; LUNG CANCER; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; WILD TYPE;

ANIMALS; APOPTOSIS; CATHEPSINS; ENDOPEPTIDASES; ENZYME ACTIVATION; HUMANS; LYSOSOMES; MODELS, BIOLOGICAL;

EID: 33344457969     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-006-3486-y     Document Type: Review

References (67)

1. Barrett AJ. Classification of peptidases. Methods Enzymol 1994; 244: 1-18.
2. MEROPS - the peptidase database. merops.sanger.ac.uk. 2003.
3. Willstätter R, Bamann E. Über die Proteasen der Magenschleinhaut. Hoppe-Seyler's Z Physiol Chem 1929; 180: 127-143.
4. Berti PJ, Storer AC. Alingment/Phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 1995; 246: 273-283.
5. Wex T, Levy B, Wex H, Bromme D. Human cathepsins F and W: A new subgroup of cathepsins. Biochem Biophys Res Communications 1999; 259: 401-407.
6. McCormick D. Secretion of cathepsin B by human gliomas in vitro. Neuropathol Appl Neurobiol 1993; 19: 146-151.
7. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000; 19: 1187-1194.
8. Wyllie AH. What is apoptosis? Histopathology 1986; 10: 995-998.
9. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-795.
10. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
11. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
12. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
13. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144: 891-901.
14. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000; 20: 929-935.
15. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62: 273-295.
16. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3: E255-E263.
17. Brunk UT, Neuzil J, Eaton JW. Lysosomal involvement in apoptosis. Redox Rep 2001; 6: 91-97.
18. Schutze S, Machleidt T, Adam D, et al. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biological Chem 1999; 274: 10203-10212.
19. Kagedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 2001; 359: 335-343.
20. Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283: G947-G956.
21. Heinrich M, Wickel M, Schneider-Brachert W, et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 1999; 18: 5252-5263.
22. Zdolsek J, Zhang H, Roberg K, Brunk U. H2O2-mediated damage to lysosomal membranes of J-774 cells. Free Radic Res Commun 1993; 18: 71-85.
23. 2 is a consequence of lysosomal rupture. Biochem J 2001; 356: 549-555.
24. Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radical Biol Med 2005; 34: 1295-1305.
25. Zhao M, Antunes F, Eaton JW, Brunk UT. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 2003; 270: 3778-3786.
26. Zhao M, Brunk UT, Eaton JW. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 2001; 509: 399-404.
27. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997; 22: 269-285.
28. Bidere N, Lorenzo HK, Carmona S, et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biological Chem 2003; 278: 31401-31411.
29. Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 2002; 62: 7139-7142.
30. Stoka V, Turk B, Schendel SL, et al. Lysosomal protease pathways to apoptosis: cleavage of bid, not Pro-caspases, is the most likely route. J Biological Chem 2000; 276: 3149-3157.
31. Houseweart MK, Vilaythong A, Yin XM, Turk B, Noebels JL, Myers RM. Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1). Cell Death Differ 2003; 10: 1329-1335.
32. Liu N, Raja SM, Zazzeroni F, et al. NF-kappaB protects from the lysosomal pathway of cell death. EMBO J 2003; 22: 5313-5322.
33. Roberts LR, Kurosawa H, Bronk SF, et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 1997; 113: 1714-1726.
34. Jones B, Roberts PJ, Faubion WA, Kominami E, Gores GJ. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol 1998; 275: G723-G730.
35. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-145.
36. Faubion WA, Gores GJ. Death receptors in liver biology and pathobiology. Hepatology 1999; 29: 1-4.
37. Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene 2004; 23: 2881-2890.
38. Vancompernolle K, Van Herreweghe F, Pynaert G, et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 1998; 438: 150-158.
39. Guicciardi ME, Deussing J, Miyoshi H, et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Infest 2000; 106: 1127-1137.
40. Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: Implications for therapeutic applications. American J Pathol 2001; 159: 2045-2054.
41. Canbay A, Guicciardi ME, Higuchi H, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest. 2003; 112: 152-159.
42. Baskin-Bey ES, Canbay A, Bronk SF, et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest. Liver Physiol. 2005; 288: G396-G402.
43. Jaattela M, Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 2003; 4: 416-423.
44. Michallet MC, Saltel F, Preville X, Flacher M, Revillard JP, Genestier L. Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: A novel mechanism of T-cell depletion. Blood 2003; 102: 3719-3726.
45. Michallet MC, Saltel F, Flacher M, Revillard JP, Genestier L. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: A possible mechanism of high dose tolerance. J Immunol 2004; 172: 5405-5414.
46. Suzuki G, Kawase Y, Koyasu S, Yahara I, Kobayashi Y, Schwartz RH. Antigen-induced suppression of the proliferative response of T cell clones. J Immunol 1988; 140: 1359-1365.
47. Critchfield JM, Racke MK, Zuniga-Pflucker JC, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139-1143.
48. Kishimoto H, Sprent J. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. J Immunol 1999; 163: 1817-1826.
49. Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Experimen Med 1996; 184: 485-492.
50. Alexander-Miller MA, Derby MA, Sarin A, Henkart PA, Berzofsky JA. Supraoptimal peptide-major histocompatibility complex causes a decrease in bcl-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes. J Experiment Med 1998; 19; 1391-1399.
51. Mlinaric-Rascan I, Turk B. B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity. FEBS Lett 2003; 553: 51-55.
52. Felbor U, Kessler B, Mothes W, et al. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci USA 2002; 99: 7883-7888.
53. Shibata M, Kanamori S, Isahara K, et al. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Communications 1998; 251: 199-203.
54. Nitatori T, Sato N, Waguri S, et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995; 15: 1001-1011.
55. Wille A, Gerber A, Heimburg A, et al. Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells. Biol Chem 2004; 385: 665-670.
56. Diment S, Leech MS, Stahl PD. Cathepsin D is membrane-associated in macrophage endosomes. J Biological Chem 1988; 263: 6901-6907.
57. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-α. EMBO J 1996; 15: 3861-3870.
58. Roberg K, Kagedal K, Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 2002; 161: 89-96.
59. Wu GS, Saftig P, Peters C, El-Deiry WS. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998; 16: 2177-2183.
60. Kagedal K, Johansson U, Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 2001; 15: 1592-1594.
61. Johansson AC, Steen H, Ollinger K, Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003; 10: 1253-1259.
62. Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Histol Histopatbol 2004; 19: 867-881.
63. Harrison JH Jr, Hoyt DG, Lazo JS. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol Pharmacol 1989; 36: 231-238.
64. Li X, Zhang H, Soledad-Conrad V, Zhuang J, Uhal BD. Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am J Physiol Lung Cell Mol Physiol. 2003; 284: L501-L507.
65. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol 2003; 163: 2523-2530.
66. Thibodeau M, Giardina C, Hubbard AK. Silica Induced Caspase Activation in Mouse Alveolar Macrophages Is Dependent upon Mitochondrial Integrity and Aspartic Proteolysis. Toxicol Sci 2003; 76: 91-101.
67. Thibodeau MS, Giardina C, Knecht DA, Helble J, Hubbard AK. Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Toxicol Sci 2004; 80: 34-48.